LIST OF CLINICAL TRIALS THAT ARE CURRENTLY RECRUITING PARTICIPANTS

Updated as of October 31, 2017

For studies that are active but not recruiting participants, please contact the Clinical Research Center. This list does not include studies under the Cellular Therapeutics Center.


Acute Venous Thromboembolism
Characterization of patients following acute venous thromboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the treatment and secondary prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice

Principal Investigator:   Dr. Mary Milagros Uy    

Learn More

 

Active Cutaneous Lupus Erythematosus
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations  and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations

Principal Investigator:   Dr. Jose Paulo Lorenzo
Co-Investigator:              Dr. Andrei Rhoneil Rodriguez

Learn More
 

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with Connective Tissue Disease-Associated  Pulmonary Arterial Hypertension

Principal Investigator: Dr. Andrei Rhoneil Rodriguez
Co-Investigator:            Dr. Jose Paulo Lorenzo


Learn More


Diabetes Mellitus 
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes

Principal Investigator:    Dr. Sylvia Capistrano-Estrada


Learn More


Liver Cancer
Phase 1 Dose Escalation Trial to evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Reximmune-C2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes) in Refractory patients with primary Hepatocellular Carcinoma or Tumors Metastatic to the Liver

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy
 

Lung Cancer
A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients with Advanced/Recurrent Non-Squamous Non-Small Cell Lung Cancer in Combination of Paclitaxel and Carboplatin
 
Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Joseph D. Parra


Learn More


Phase 3 Open-label, Multicentre, Randomised Trial to Establish Safety & Efficacy of an EGF Cancer Vaccine in Inoperable, Stage IV Biomarker Positive,Wild Type EGF-R NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy

Learn More
 

Pancreatic Cancer
A Phase III, Open-label, Randomized Study of the Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Principal Investigator:   Dr. Ma. Belen M. Tamayo
Co-Investigator:              Dr. Regina Edusma-Dy

Learn More


 

Systemic Lupus Erythematosus
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, and Safety of BIIB059 in Subjects with Systemic Lupus Erythematosus and Active Skin Manifestations  and in Subjects with Active Cutaneous Lupus Erythematosus with or without Systemic Manifestations

Principal Investigator: Dr. Jose Paulo Lorenzo
Co-Investigator:            Dr. Andrei Rhoneil Rodriguez


Learn More